Matteo Lambertini MD PhD; San Antonio Breast Cancer Symposium: ALTTO Trial Shows Adjuvant Aromatase Inhibitors Outperform Tamoxifen in Patients with...
2025 San Antonio Breast Cancer Symposium: Selective Estrogen Degrader Giredestrant Improves on Standard Endocrine Therapy for Patients with ER...
AudioMedica News AACR In New Partnership For San Antonio Breast Cancer Symposium Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x...




